Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Infusion of alloanergized donor lymphocytes after CD34-selected haploidentical myeloablative hematopoietic stem cell transplantation.

Davies JK, Brennan LL, Wingard J, Cogle CR, Kapoor N, Shah AJ, Dey BR, Spitzer TR, De Lima M, Cooper LJ, Thall P, Champlin RE, Nadler LM, Guinan EC.

Clin Cancer Res. 2018 May 16. pii: clincanres.0449.2018. doi: 10.1158/1078-0432.CCR-18-0449. [Epub ahead of print]

PMID:
29769208
2.

Pilot experience with opebacan/rBPI 21 in myeloablative hematopoietic cell transplantation.

Guinan E, Avigan DE, Soiffer RJ, Bunin NJ, Brennan LL, Bergelson I, Brightman S, Ozonoff A, Scannon PJ, Levy O.

F1000Res. 2015 Dec 21;4:1480. doi: 10.12688/f1000research.7558.1. eCollection 2015.

3.

Ex Vivo Costimulatory Blockade to Generate Regulatory T Cells From Patients Awaiting Kidney Transplantation.

Guinan EC, Cole GA, Wylie WH, Kelner RH, Janec KJ, Yuan H, Oppatt J, Brennan LL, Turka LA, Markmann J.

Am J Transplant. 2016 Jul;16(7):2187-95. doi: 10.1111/ajt.13725. Epub 2016 Mar 11.

4.

Alloanergization of human T cells results in expansion of alloantigen-specific CD8(+) CD28(-) suppressor cells.

Barbon CM, Davies JK, Voskertchian A, Kelner RH, Brennan LL, Nadler LM, Guinan EC.

Am J Transplant. 2014 Feb;14(2):305-18. doi: 10.1111/ajt.12575. Epub 2014 Jan 10.

5.

Effect of weight on outcomes of children undergoing hematopoietic cell transplantation.

Myers LC, Sun P, Brennan LL, London WB, Guinan EC.

Pediatr Hematol Oncol. 2013 Mar;30(2):116-30. doi: 10.3109/08880018.2012.743201. Epub 2012 Nov 28. Review.

PMID:
23189973
6.

Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies.

Davies JK, Gribben JG, Brennan LL, Yuk D, Nadler LM, Guinan EC.

Blood. 2008 Sep 15;112(6):2232-41. doi: 10.1182/blood-2008-03-143636. Epub 2008 Jul 10.

7.

Transplantation of anergic histoincompatible bone marrow allografts.

Guinan EC, Boussiotis VA, Neuberg D, Brennan LL, Hirano N, Nadler LM, Gribben JG.

N Engl J Med. 1999 Jun 3;340(22):1704-14.

8.

Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma.

Parsons SK, Neault MW, Lehmann LE, Brennan LL, Eickhoff CE, Kretschmar CS, Diller LR.

Bone Marrow Transplant. 1998 Oct;22(7):669-74.

Supplemental Content

Loading ...
Support Center